James Scuffham

James Scuffham is a Consultant Clinical Scientist and Head of Nuclear Medicine Physics at the Royal Surrey NHS Foundation Trust, where he leads a team of medical physicists providing scientific support to nuclear medicine services across both the NHS and private sector.

With over 20 years’ experience in Medical Physics and Nuclear Medicine, James has led several significant service developments at the Royal Surrey, including the introduction of Radium-223 and Lutetium-177 therapies into clinical practice and the achievement of BS 70000 accreditation through UKAS. He is also actively involved in clinical and academic research, with interests spanning molecular radiotherapy dosimetry, radiomics, novel detector instrumentation and metrology in nuclear medicine. He has led the establishment of several landmark molecular radiotherapy clinical trials at the Royal Surrey, including HiLo and ALSYMPCA.

James holds a joint appointment with the National Physical Laboratory, providing clinical direction to the work of its Nuclear Medicine Metrology Group. He is also a Visiting Professor at the University of Surrey, where he teaches on the MSc Medical Physics course and co-supervises Master’s and PhD research projects.